Degenerative Disc Disease Treatment Growth Trajectory: Key Forecasts and Strategic Insights
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Degenerative Disc Disease Treatment Market Size Shifted, And What Is the Outlook Through 2034?
The market for degenerative disc disease treatment has experienced significant growth in the past few years. The market, which currently stands at $27.07 billion in 2024, is predicted to rise to $28.79 billion in 2025, translating to a compound annual growth rate (CAGR) of 6.3%. The market expansion during the historical period is mainly due to factors such as an aging population, inactive lifestyle, advancements in medical technology, heightened awareness, escalating obesity rates, an increasing number of sports injuries, and the widening of healthcare access.
The market for degenerative disc disease treatment is expected to witness a robust growth in the coming years. By 2029, it is predicted to surge to $37.41 billion, with a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this projected growth during the forecast period include increased healthcare spending, the rising demand for minimally invasive procedures, improved patient awareness, broader clinical research, and an increasing worldwide prevalence of spinal disorders. The forecast period will also be characterized by major trends such as the incorporation of Artificial Intelligence and machine learning, progress in regenerative medicine, advancements in minimally invasive surgery, the use of wearable technology, 3D printing for personalized implants, the rise of telemedicine and remote consultations, along with a focus on personalized medicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18784&type=smp
Which Factors and External Forces Are Driving Demand in the Degenerative Disc Disease Treatment Market?
The escalating incidents of sports injuries are predicted to stimulate growth in the degenerative disc disease treatment market. Sports injuries, which pertain to any physical trauma sustained by athletes or people partaking in physical activity, can be caused by sudden impact, overuse, or incorrect techniques. The surge in sports injuries can be linked to factors like higher engagement rates, more rigorous training schedules, and an enhanced focus on competitive performance. If disc degeneration hampers the performance and agility of athletes, degenerative disc disease treatment can be used to manage entrenched spinal pain and reinstate function. For example, in November 2023, data from Howden Group Holdings Ltd, a UK-based insurance intermediary firm, showed that by October 2022, injuries had kept players out of action for an average of 11.35 days prior to tournaments. This figure escalated to 19.41 days by January 2023. As such, the upturn in sports injuries is fuelling the expansion of the degenerative disc disease treatment market.
Which Segments in the Degenerative Disc Disease Treatment Offer the Most Growth?
The degenerative disc disease treatmentmarket covered in this report is segmented –
1) By Type: Conventional Drugs, Novel Therapies
2) By Route Of Administration: Oral, Injectable
3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Center
Subsegments:
1) By Conventional Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Muscle Relaxants, Corticosteroids, Antidepressants
2) By Novel Therapies: Gene Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Biologic Agents, Regenerative Medicine, Cell-Based Therapies, Growth Factor Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18784&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Degenerative Disc Disease Treatment Market?# Market?
North America was the largest region in the degenerative disc disease treatment market in 2024. The regions covered in the degenerative disc disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theDegenerative Disc Disease Treatment Market’s Growth?
Leading businesses in the degenerative disc disease treatment market are striving to introduce unique therapies, such as injectable disc cell therapy (IDCT), to enhance patient results by boosting disc volume, easing lower back pain, and diminishing reliance on pain drugs. The restorative treatment, injectable disc cell therapy (IDCT), is specifically designed for symptomatic lumbar degenerative disc disease. For example, in February 2023, DiscGenics Inc., a biopharmaceutical firm based in the U.S., was granted FDA regenerative medicine advanced therapy designation for their injectable disc cell therapy (IDCT), targeting symptomatic lumbar degenerative disc disease. This pioneering therapy employs a live progenitor cell group extracted from donated adult human intervertebral disc tissue. IDCT holds promising potential to amplify disc volume, relieve lower back pain and curtail the necessity for pain medications in affected patients.
View the full report here:
What Are the Key Elements That Define the Degenerative Disc Disease Treatment Market?
Degenerative disc disease treatment refers to various medical approaches aimed at alleviating symptoms and improving function in individuals with degenerative disc disease, a condition where the spinal discs lose their cushioning ability over time. Treatments may include physical therapy, pain management with medications, lifestyle modifications, and, in some cases, surgical interventions such as discectomy or spinal fusion to relieve pressure on nerves and stabilize the spine.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18784
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
